Long-Acting Lipoglycopeptides for Skin and Soft Tissue Infections : Implementation Into Practice

Hear Kyle Molina, PharmD, BCIDP, discuss key considerations to ensure successful implementation of long-acting lipoglycopeptides for ABSSSI treatment into practice, such as justifying cost, targeting the right patient population, selecting between infusion locations, and maximizing institutional impact.